Clinical trials
Phase 2/3 Hemophilia A trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baxalta now part of Shire | 6 |
| Bayer | 2 |
| Chulalongkorn University | 2 |
| CSL Behring | 1 |
| Dhaka Medical College | 1 |
| Genzyme, a Sanofi Company | 1 |
| Georgetown University | 1 |
| Shanghai Xinzhi BioMed Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 15 |
| Hemarthrosis | 2 |
| Blood Coagulation Disorders | 1 |
| Coagulation Protein Disorders | 1 |
| Hematologic Diseases | 1 |
| Hemophilia B | 1 |
| Hemorrhagic Disorders | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.